Ticker Details
United Therapeutics Corporation United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients.
IPO Date:	June 17, 1999
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$22.01B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.91 | 1.43%
Avg Daily Range (30 D):	$6.61 | 1.26%
Avg Daily Range (90 D):	$5.83 | 1.06%

Institutional Daily Volume
Avg Daily Volume:	.52M
Avg Daily Volume (30 D):	.35M
Avg Daily Volume (90 D):	.36M

Trade Size
Avg Trade Size (Sh.):	82
Avg Trade Size (Sh.) (30 D):	22
Avg Trade Size (Sh.) (90 D):	23

Institutional Trades
Total Institutional Trades:	14,684
Avg Institutional Trade:	$5.78M
Avg Institutional Trade (30 D):	$36.02M
Avg Institutional Trade (90 D):	$35.57M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$11.13M
Avg Closing Trade (30 D):	$35.5M
Avg Closing Trade (90 D):	$46.77M
Avg Closing Volume:	59.92K

News

Jul 28, 2026 @ 9:07 PM United Therapeutics CEO Sells $5 Million of Shares... Source: Brendan Coffey

Jun 30, 2026 @ 4:26 AM Big Pharma Has a Case of Merger Mania Source: Motley Fool Staff

Jun 10, 2026 @ 6:17 PM iShares U.S. Pharmaceuticals ETF Tops Simplify Hea... Source: Brendan Coffey

Jun 9, 2026 @ 3:10 PM These 3 Stocks Lowered Their Share Counts Drastica... Source: Leo Miller

May 19, 2026 @ 5:00 PM Pulmonary Arterial Hypertension Clinical Trial Pip... Source: Delveinsight

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$30.23	$7.82	$6.32
Diluted EPS	$27.91	$7.27	$5.82
Revenue	$3.15B	$783.3M	$781.5M
Gross Profit	$2.72B	$683.8M	$648.1M
Net Income / Loss	$1.31B	$333M	$274.9M
Operating Income / Loss	$1.4B	$330.8M	$325.8M
Cost of Revenue	$437.2M	$99.5M	$133.4M
Net Cash Flow	$210.1M	$523.5M	$-277.4M
PE Ratio

Splits
Sep 23, 2009	2:1